CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery-Reference-Cited by-同舟云学术

CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery

Published:2017-06-22 Issue:15 Volume:117 Page:9874-9906
ISSN:0009-2665
Container-title:Chemical Reviews
language:en
Short-container-title:Chem. Rev.

Author:

Wang Hong-Xia¹,Li Mingqiang¹^ORCID,Lee Ciaran M.²,Chakraborty Syandan¹,Kim Hae-Won³^ORCID,Bao Gang²^ORCID,Leong Kam W.¹^ORCID

Affiliation:

1. Department of Biomedical Engineering, Columbia University, New York, New York 10027, United States

2. Department of Bioengineering, Rice University, Houston, Texas 77005, United States

3. Institute of Tissue Regeneration Engineering (ITREN) and Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Korea

Funder

National Center for Advancing Translational Sciences

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

National Institute of General Medical Sciences

Ministry of Science, ICT and Future Planning

Guandong Province

Publisher

American Chemical Society (ACS)

Subject

General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.chemrev.6b00799

Reference301 articles.

1. State-of-the-art gene-based therapies: the road ahead

2. Therapeutic genome editing: prospects and challenges

3. Altering the Genome by Homologous Recombination

4. Homing Endonucleases: From Microbial Genetic Invaders to Reagents for Targeted DNA Modification

5. Genome editing with engineered zinc finger nucleases

Cited by 445 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-based dual-aptamer proximity ligation coupled hybridization chain reaction for precise detection of tumor extracellular vesicles and cancer diagnosis;Talanta;2024-12

2. Recent advances and applications of the CRISPR-Cas system in the gene therapy of blood disorders;Gene;2024-12

3. Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer;Biomaterials;2024-09

4. CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL;International Journal of Pharmacy and Pharmaceutical Sciences;2024-09-01

5. Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing;Small Science;2024-07-25